IXINITY Statement on Product Availability

March 17, 2020

The following is information provided by IXINITY. Read the full statement here. “The health and safety of individuals who rely on our products, their caregivers and community members, healthcare professionals, and our own team is of upmost importance to Medexus Pharma, the company behind IXINITY.聽 We want to reassure the community that we currently do […]

FDA Approves New Hemophilia B Treatment

April 30, 2015

  Note: This is an edited version of a Emergent BioSolutions Inc.聽press release. To read the full release,聽click here. Emergent BioSolutions Inc. announced on Thursday, April 29 the聽U.S. Food and Drug Administration聽(FDA) has approved IXINITY庐, an intravenous recombinant human coagulation factor IX therapeutic for the control and prevention of bleeding episodes and for perioperative management […]

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.